Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,069 | 373 | 87.1% |
| Debt forgiveness | $706.28 | 2 | 10.1% |
| Education | $136.74 | 6 | 2.0% |
| Gift | $53.75 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,165 | 44 | $0 (2022) |
| Baxter Healthcare | $706.28 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $697.77 | 45 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $639.58 | 34 | $0 (2024) |
| PFIZER INC. | $403.82 | 38 | $0 (2020) |
| ABBVIE INC. | $400.74 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $380.88 | 23 | $0 (2024) |
| Indivior Inc. | $331.96 | 18 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $270.71 | 29 | $0 (2021) |
| Astellas Pharma US Inc | $263.62 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.13 | 5 | Phathom Pharmaceuticals, Inc. ($83.20) |
| 2023 | $356.05 | 13 | Baxter Healthcare ($118.14) |
| 2022 | $689.98 | 7 | Baxter Healthcare ($588.14) |
| 2021 | $119.07 | 7 | Teva Pharmaceuticals USA, Inc. ($51.06) |
| 2020 | $439.63 | 24 | Teva Pharmaceuticals USA, Inc. ($92.07) |
| 2019 | $1,564 | 104 | Janssen Pharmaceuticals, Inc ($279.53) |
| 2018 | $1,157 | 74 | AstraZeneca Pharmaceuticals LP ($208.34) |
| 2017 | $2,478 | 148 | Boehringer Ingelheim Pharmaceuticals, Inc. ($709.93) |
All Payment Transactions
382 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $83.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Oncology | ||||||
| 12/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Oncology | ||||||
| 07/14/2023 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $118.14 | General |
| 06/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Oncology | ||||||
| 03/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: INSOMNIA | ||||||
| 02/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: DIABETES | ||||||
| 10/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/23/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/06/2022 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $588.14 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 602 | 822 | $161,980 | $59,151 |
| 2022 | 9 | 658 | 883 | $178,835 | $67,204 |
| 2021 | 8 | 622 | 832 | $157,960 | $61,056 |
| 2020 | 8 | 557 | 775 | $160,760 | $49,611 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 214 | $58,550 | $18,756 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $25,200 | $16,541 | 65.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 98 | 181 | $36,200 | $12,317 | 34.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 48 | 58 | $15,950 | $5,404 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 44 | $9,680 | $2,855 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,900 | $1,491 | 38.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 114 | 120 | $10,800 | $1,139 | 10.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 68 | $1,700 | $647.36 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 138 | 138 | $27,600 | $18,629 | 67.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 174 | $47,575 | $16,306 | 34.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 109 | 202 | $40,400 | $13,438 | 33.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 52 | 73 | $20,075 | $6,437 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 58 | $12,715 | $4,005 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 25 | $10,700 | $3,464 | 32.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $5,825 | $3,091 | 53.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 127 | 138 | $12,420 | $1,249 | 10.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 61 | $1,525 | $584.06 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 151 | 151 | $30,200 | $20,829 | 69.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 189 | $51,825 | $16,490 | 31.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 96 | 199 | $39,800 | $13,776 | 34.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 40 | 45 | $12,375 | $3,708 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 31 | $5,470 | $2,217 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 15 | $4,400 | $2,115 | 48.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 128 | 136 | $12,240 | $1,279 | 10.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 36 | 66 | $1,650 | $640.86 | 38.8% |
About Dr. James Cardi, M.D
Dr. James Cardi, M.D is a Internal Medicine healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104890292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Cardi, M.D has received a total of $6,965 in payments from pharmaceutical and medical device companies, with $161.13 received in 2024. These payments were reported across 382 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,069).
As a Medicare-enrolled provider, Cardi has provided services to 2,439 Medicare beneficiaries, totaling 3,312 services with total Medicare billing of $237,021. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cranston, RI
- Active Since 02/15/2006
- Last Updated 07/24/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104890292
Products in Payments
- XARELTO (Drug) $583.58
- JARDIANCE (Drug) $469.17
- SYMBICORT (Drug) $394.33
- SUBLOCADE (Drug) $278.16
- STIOLTO RESPIMAT (Drug) $230.84
- FARXIGA (Drug) $183.05
- Creon (Drug) $174.47
- VRAYLAR (Drug) $149.92
- TRELEGY ELLIPTA (Drug) $143.75
- AJOVY (Biological) $143.13
- Trintellix (Drug) $141.51
- VIAGRA (Drug) $131.16
- ENTRESTO (Drug) $130.26
- CHANTIX (Drug) $128.21
- AJOVY (Drug) $123.78
- ANORO (Drug) $122.02
- ELIQUIS (Drug) $122.00
- Mitigare (Drug) $121.41
- BREO (Drug) $115.11
- INVOKANA (Drug) $114.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cranston
Dr. Gregory Allen, D.o, D.O
Internal Medicine — Payments: $39,714
Dr. Dennis Botelho, Md, MD
Internal Medicine — Payments: $15,096
Dr. Usha Panneerselvam, Md, MD
Internal Medicine — Payments: $11,450
Mr. Stephen Beaupre, Md, MD
Internal Medicine — Payments: $9,665
Mrs. Olga Tverskaya, M.d, M.D
Internal Medicine — Payments: $6,262
Ralph Santoro, M.d, M.D
Internal Medicine — Payments: $5,810